BCLSI
Bain Capital Life Sciences Investors’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.95M | Hold |
2,485,638
| – | – | 1.12% | 16 |
|
|
2025
Q1 | $7.43M | Hold |
2,485,638
| – | – | 1.1% | 13 |
|
|
2024
Q4 | $8.33M | Hold |
2,485,638
| – | – | 0.98% | 16 |
|
|
2024
Q3 | $8.33M | Hold |
2,485,638
| – | – | 0.87% | 15 |
|
|
2024
Q2 | $8.23M | Hold |
2,485,638
| – | – | 0.9% | 17 |
|
|
2024
Q1 | $10M | Hold |
2,485,638
| – | – | 0.81% | 19 |
|
|
2023
Q4 | $7.58M | Hold |
2,485,638
| – | – | 0.73% | 21 |
|
|
2023
Q3 | $7.46M | Hold |
2,485,638
| – | – | 0.83% | 24 |
|
|
2023
Q2 | $9.3M | Hold |
2,485,638
| – | – | 0.96% | 22 |
|
|
2023
Q1 | $8.33M | Hold |
2,485,638
| – | – | 1.04% | 25 |
|
|
2022
Q4 | $12M | Hold |
2,485,638
| – | – | 1.34% | 21 |
|
|
2022
Q3 | $14.1M | Hold |
2,485,638
| – | – | 1.69% | 19 |
|
|
2022
Q2 | $17.6M | Hold |
2,485,638
| – | – | 2.07% | 16 |
|
|
2022
Q1 | $17.9M | Hold |
2,485,638
| – | – | 1.74% | 16 |
|
|
2021
Q4 | $22.2M | Sell |
2,485,638
-1,214,362
| -33% | -$10.9M | 1.76% | 15 |
|
|
2021
Q3 | $130M | Sell |
3,700,000
-1,915,659
| -34% | -$67.2M | 8.05% | 4 |
|
|
2021
Q2 | $121M | Hold |
5,615,659
| – | – | 7.9% | 2 |
|
|
2021
Q1 | $347M | Hold |
5,615,659
| – | – | 19.64% | 2 |
|
|
2020
Q4 | $235M | Buy |
+5,615,659
| New | +$235M | 14.73% | 2 |
|